Monitor for any activist campaigns or further filing details regarding the share increase. The doubling of authorized shares could lead to dilution if issued.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 28 $2.86entry
- T+1 · 7mo ago −2.80%α −2.79% · $2.78
- T+5 · 7mo ago +45.10%α +43.41% · $4.15
- T+20 · 6mo ago +33.92%α +28.46% · $3.83
- T+60 · 4mo ago −4.90%α −8.88% · $2.72
Price Chart
How similar events traded
Executive Summary
Cabaletta Bio files additional proxy materials for its 2026 annual meeting. The board recommends voting FOR all proposals including election of two Class I directors, ratification of Ernst & Young as auditor, approval of amendments to the 2019 stock plan and charter to double authorized shares, say-on-pay, and adjournment. The most notable item is the proposed increase in authorized common stock from 300M to 600M, signaling potential future dilution.
Key Financial Metrics
Key Facts
- Annual meeting scheduled for June 9, 2026
- Stockholders of record as of April 20, 2026
- Proposal to double authorized shares from 300M to 600M
- Amendment to 2019 Stock Option and Incentive Plan
- Board unanimously recommends FOR all six proposals
Financial Impact
Not specified
Risk Factors
- Potential shareholder dilution if authorized shares are issued
- No material financial data disclosed in this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-183564 |
| Document: 0001193125-26-183564-index-headers.html | 0001193125-26-183564 |
| Document: 0001193125-26-183564-index.html | 0001193125-26-183564 |
| Document: 0001193125-26-183564.txt | 0001193125-26-183564 |
Track record
29 reports on CABA
4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +31.59% at T+60 after the May 4, 2026 report. 5 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $1.15 Now $1.11 −3.09% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.32 Now $1.11 −15.91% settles Nov 23
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $1.33 Now $1.11 −16.54% settles Nov 19
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $1.45 Now $1.11 −23.45% settles Nov 17
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $1.50 to $1.11 Now $1.11 −26.00% ▼ −26.00% −24.31% vs SPY
- Nov 8, 20268d ago Press Release Bullish 6/10 Entry $1.50 to $1.11 Now $1.11 −26.00% ▼ −26.00% −24.31% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $1.30 to $1.28 Now $1.11 −14.62% ▼ −1.54% −4.13% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $1.30 to $1.28 Now $1.11 −14.62% ▼ −1.54% −4.13% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $1.28 to $1.33 Now $1.11 −13.28% ▲ +3.91% +0.62% vs SPY
- Nov 5, 202611d ago Press Release Neutral 4/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers